Tuggle KL et al.: Characterization of Defects in Ion Transport and Tissue Development in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-Knockout Rats. The CFTR Rat Models Core was ...

The CFTR Protein Distribution Core offers high-quality, full-length recombinant cystic fibrosis transmembrane conductance regulator (CFTR) proteins expressed in and purified from mammalian cells. Wild ...

Cystic fibrosis transmembrane conductance regulator (CFTR) modulators are a class of medications that help improve the function of the atypical protein causing cystic fibrosis. According to the ...

Recent research has focused on innovative treatments that target the underlying causes of CF, particularly through the development of CFTR (cystic fibrosis transmembrane conductance regulator ...

ReCode Therapeutics is set to secure up to $15m in additional funding from the Cystic Fibrosis ... to existing cystic fibrosis transmembrane conductance regulator (CFTR) modulators.

A Waltham biotech focused on cystic fibrosis and a Boston biotech led by serial founder Gary Glick are the first ...

It is the first once-daily treatment for cystic fibrosis transmembrane conductance regulator (CFTR) modulator, Vertex said. Alyftrek is Vertex's fifth CFTR modulator to secure FDA approval.

The commitment of organizations like the Cystic Fibrosis Foundation to global research funding and access initiatives has further propelled market growth. Additionally, major pharmaceutical companies, ...

ages 2 and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation that is responsive to TRIKAFTA based on clinical and/or ...

The medicine, called trikafta, can treat cystic fibrosis patients who have at least one F508del mutation in the transmembrane conductance regulator ... non-F508del CFTR mutations have been added ...